Revvity, Inc. (RVTY) Financial Statements

Historical financial data — 20 statements covering FY2021–FY2025

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and in...

Revvity, Inc.'s revenue increased 3.7% year over year, from $2.76B to $2.86B.

Net income decreased 10.8% over the same period, from $270.4M to $241.2M.

Over the 4-year period from FY2021 to FY2025, revenue declined by 25% in total.

Total debt decreased by 16.5% to $2.63B.

The debt-to-equity ratio stands at 0.36, indicating a moderate leverage profile.

Operating cash flow declined 7.2% to $582.9M.

Revvity, Inc. maintains a moderate net profit margin of 8.4%.

Recent Financial Statements

Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).

PeriodRevenueNet IncomeGross ProfitEBITOp. Cash FlowTotal AssetsTotal DebtEquity
Q3 FY2024$684.0M-1.1%$94.4M$384.8M$98.2M$147.9M$12.77B$3.19B$7.92B
Q4 FY2024$729.4M+6.6%$94.6M$412.3M$118.8M$174.2M$12.39B$3.15B$7.67B
Q1 FY2025$664.8M-8.9%$42.2M$375.5M$72.2M$128.2M$12.36B$3.17B$7.64B
Q2 FY2025$720.3M+8.4%$53.9M$392.6M$90.8M$134.3M$12.36B$3.21B$7.56B
Q3 FY2025$698.9M-3.0%$46.7M$374.6M$81.9M$138.5M$12.14B$2.63B$7.38B
Q4 FY2025$772.1M+10.5%$98.4M$421.7M$111.7M$182.0M$12.17B$2.63B$7.25B
Q1 FY2026$711.1M-7.9%$40.7M$387.7M$75.9M$115.2MN/AN/AN/A
Q2 FY2026$729.7M+2.6%$51.8M$416.9M$89.3M$191.9MN/AN/AN/A

Balance Sheet Summary (FY2025)

Total Assets
$12.17B
Total Liabilities
$4.92B
Total Equity
$7.25B
Cash & Equivalents
$919.9M
Total Debt
$2.63B
Current Assets
$2.24B
Current Liabilities
$1.33B
Retained Earnings
$6.05B
Current Price: $152.64
Market Cap: $17.0B
Sector: Technology

Revvity, Inc. (RVTY) Financial Statements & Revenue History

Revvity, Inc. (RVTY) is a US-listed stock operating in the Technology sector, specifically the Laboratory Analytical Instruments industry trading at $152.64 with a market capitalization of $17. This page provides 20 historical financial statements for Revvity, Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Revvity, Inc. reported revenue of $2.9 billion, representing 3.7% year-over-year growth. The net profit margin of 8.4% indicates moderate profitability. The debt-to-equity ratio of 0.36 shows conservative leverage.

RVTY Income Statement, Balance Sheet & Cash Flow

The financial statements table above shows Revvity, Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether RVTY is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.

  • Revenue trend: Track RVTY's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
  • Profitability: Net income and gross profit margins reveal how efficiently Revvity, Inc. converts revenue into earnings.
  • Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of RVTY's financial position and leverage.
  • Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.

How to Use RVTY Financial Data

Investors use Revvity, Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:

Financial data is sourced from Revvity, Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.RVTY trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.

Related opportunities

Moving today in Technology
More Laboratory Analytical Instruments stocks
Cheaper alternatives
Similar fundamentals